120 related articles for article (PubMed ID: 11017939)
1. Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA.
Nurmikko P; Väisänen V; Piironen T; Lindgren S; Lilja H; Pettersson K
Clin Chem; 2000 Oct; 46(10):1610-8. PubMed ID: 11017939
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146.
Nurmikko P; Pettersson K; Piironen T; Hugosson J; Lilja H
Clin Chem; 2001 Aug; 47(8):1415-23. PubMed ID: 11468231
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of prostate-specific antigen with monoclonal antibodies.
Jette DC; Kreutz FT; Malcolm BA; Wishart DS; Noujaim AA; Suresh MR
Clin Chem; 1996 Dec; 42(12):1961-9. PubMed ID: 8969633
[TBL] [Abstract][Full Text] [Related]
4. Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling.
Michel S; Deléage G; Charrier JP; Passagot J; Battail-Poirot N; Sibai G; Jolivet M; Jolivet-Reynaud C
Clin Chem; 1999 May; 45(5):638-50. PubMed ID: 10222350
[TBL] [Abstract][Full Text] [Related]
5. Characterization of novel monoclonal antibodies for prostate-specific antigen (PSA) with potency to recognize PSA bound to alpha 2-macroglobulin.
Baumgart Y; Otto A; Schäfer A; Usbeck E; Cott C; Schott A; Tornack M; Wenzel A; Mossie A; Birkenmeier G
Clin Chem; 2005 Jan; 51(1):84-92. PubMed ID: 15528296
[TBL] [Abstract][Full Text] [Related]
6. Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
Leinonen J; Niemelä P; Lövgren J; Bocchi L; Pettersson K; Nevanlinna H; Stenman UH
J Immunol Methods; 2004 Jun; 289(1-2):157-67. PubMed ID: 15251421
[TBL] [Abstract][Full Text] [Related]
7. Selective recognition of enzymatically active prostate-specific antigen (PSA) by anti-PSA monoclonal antibodies.
Michel S; Collomb-Clerc E; Geourjon C; Charrier JP; Passagot J; Courty Y; Deléage G; Jolivet-Reynaud C
J Mol Recognit; 2005; 18(3):225-35. PubMed ID: 15593306
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the C-terminal end of the prostrate-specific antigen in a conformational epitope: characterization by proteolytic degradation of monoclonal antibody-bound antigen and mass spectrometry.
Michel S; Forest E; Pétillot Y; Deléage G; Heuzé-Vourc'h N; Courty Y; Lascoux D; Jolivet M; Jolivet-Reynaud C
J Mol Recognit; 2001; 14(6):406-13. PubMed ID: 11757074
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen: characterization of epitopes by synthetic peptide mapping and inhibition studies.
Corey E; Wegner SK; Corey MJ; Vessella RL
Clin Chem; 1997 Apr; 43(4):575-84. PubMed ID: 9105257
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of antibodies against prostate-specific antigen with use of peptide libraries.
Leinonen J; Wu P; Stenman UH
Clin Chem; 2002 Dec; 48(12):2208-16. PubMed ID: 12446478
[TBL] [Abstract][Full Text] [Related]
11. In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen.
Correale P; Walmsley K; Nieroda C; Zaremba S; Zhu M; Schlom J; Tsang KY
J Natl Cancer Inst; 1997 Feb; 89(4):293-300. PubMed ID: 9048833
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.
Michel S; Charrier JP; Deleage G; Battail-Poirot N; Jolivet M; Jolivet-Reynaud C
J Urol; 2001 Jan; 165(1):301-6. PubMed ID: 11125429
[TBL] [Abstract][Full Text] [Related]
13. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen.
Becker C; Wigheden I; Lilja H
Tumour Biol; 1999; 20 Suppl 1():13-7. PubMed ID: 10628403
[TBL] [Abstract][Full Text] [Related]
14. Immunological grouping of 53 antibodies against prostate-specific antigen.
Slota J; Lauren L; Rapp J; Dowell B
Tumour Biol; 1999; 20 Suppl 1():70-4. PubMed ID: 10628411
[TBL] [Abstract][Full Text] [Related]
15. Characterization and measurement of prostate-specific antigen using monoclonal antibodies.
Bélanger A; Rong PM; Liu S; Lavoie L; Labrie F
Clin Invest Med; 1993 Dec; 16(6):409-14. PubMed ID: 7516829
[TBL] [Abstract][Full Text] [Related]
16. Phage display aided improvement of a unique prostate-specific antigen (PSA) antibody unreactive with Lys(145)-Lys(146) internally cleaved forms.
Liton MF; Peltola MT; Vehniäinen M; Kuusela E; Pettersson T; Lamminmäki U; Pettersson K; Brockmann EC
J Immunol Methods; 2015 Jul; 422():72-9. PubMed ID: 25889751
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays.
Corey E; Wegner SK; Stray JE; Corey MJ; Arfman EW; Lange PH; Vessella RL
Int J Cancer; 1997 Jun; 71(6):1019-28. PubMed ID: 9185706
[TBL] [Abstract][Full Text] [Related]
18. Epitope analysis of a prostate-specific antigen (PSA) C-terminal-specific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays.
Nagasaki H; Watanabe M; Komatsu N; Kaneko T; Dubé JY; Kajita T; Saitoh Y; Ohta Y
Clin Chem; 1999 Apr; 45(4):486-96. PubMed ID: 10102908
[TBL] [Abstract][Full Text] [Related]
19. Relative affinity and specificity of monoclonal antibodies against prostate-specific antigen.
Jette DC; Kreutz FT; Suresh MR
Tumour Biol; 1999; 20 Suppl 1():24-7. PubMed ID: 10628405
[TBL] [Abstract][Full Text] [Related]
20. Characterization of antibodies to prostate-specific antigen.
Nilsson O; Andersson I; Peter A; Karlsson B
Tumour Biol; 1999; 20 Suppl 1():43-51. PubMed ID: 10628409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
